Viatris (VTRS) Total Debt (2019 - 2026)
Viatris (VTRS) recorded quarterly Total Debt of $14.3 billion in Q1 2026, little changed quarter-over-quarter from $14.4 billion in Q4 2025, and down 9.51% on a YoY basis from $15.9 billion in Q1 2025.
Viatris (VTRS) Total Debt (2019 - 2026) Analysis & Trends
Viatris' Total Debt history runs 8 years deep, the most recent figure standing at $14.3 billion for Q1 2026.
- In Q1 2026, Total Debt fell 9.51% year-over-year to $14.3 billion; the TTM figure through Mar 2026 stood at $14.3 billion (down 9.51% YoY), while the FY2025 annual figure was $14.4 billion, up 2.59% from the prior year.
- Total Debt was $14.3 billion for Q1 2026 at Viatris, roughly flat from $14.4 billion in the prior quarter.
- In the past five years, Total Debt ranged from a high of $21.4 billion in Q1 2022 to a low of $14.0 billion in Q4 2024.
- Historically, Total Debt has averaged $17.2 billion across 5 years, with a median of $18.0 billion in 2024.
- The sharpest annual moves came in 2024 and 2025: Total Debt slipped 22.49% in 2024, then rose 2.59% in 2025.
- A 5-year view of Total Debt shows it stood at $19.3 billion in 2022, then slipped by 5.93% to $18.1 billion in 2023, then declined by 22.49% to $14.0 billion in 2024, then gained by 2.59% to $14.4 billion in 2025, then dropped by 0.46% to $14.3 billion in 2026.
- The last three Total Debt figures came in at $14.3 billion (Q1 2026), $14.4 billion (Q4 2025), and $14.4 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 16.63 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 9.05 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 3.53 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 3.99 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.51 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 570.41 Mn |
| 10 | Viatris | - | - | 1.16 Bn | 14.34 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.34 Bn |
| Dec 31, 2025 | 14.41 Bn |
| Sep 30, 2025 | 14.44 Bn |
| Jun 30, 2025 | 14.47 Bn |
| Mar 31, 2025 | 15.85 Bn |
| Dec 31, 2024 | 14.05 Bn |
| Sep 30, 2024 | 15.98 Bn |
| Jun 30, 2024 | 16.40 Bn |
| Mar 31, 2024 | 17.97 Bn |
| Dec 31, 2023 | 18.12 Bn |
| Sep 30, 2023 | 18.38 Bn |
| Jun 30, 2023 | 18.57 Bn |
| Mar 31, 2023 | 18.27 Bn |
| Dec 31, 2022 | 19.27 Bn |
| Sep 30, 2022 | 19.48 Bn |
| Jun 30, 2022 | 20.23 Bn |
| Mar 31, 2022 | 21.37 Bn |
| Dec 31, 2021 | 21.58 Bn |
| Sep 30, 2021 | 21.56 Bn |
| Jun 30, 2021 | 22.22 Bn |